ArticleFrontiers in computational neuroscience2025
Interpretable machine learning for precision cognitive aging.
Article in Frontiers in computational neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Interpretable and explainable artificial intelligence for wearable sensor-based fall risk assessment in older adults: a systematic review with considerations for prosthetics and orthotics.Frontiers in computational neuroscience · 2026Pooled it
- Hypothesis Generation via Interpretable Machine Learning: A Case Study on Risk Factors for Postradiation Therapy Lung Cancer Recurrence.Advances in radiation oncology · 2026Article
- Depression prediction and key factors: A comparative analysis of logistic regression and machine learning models.PloS one · 2026Article
- Interpretable Prediction of Myocardial Infarction Using Explainable Boosting Machines: A Biomarker-Based Machine Learning Approach.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Machine performance has surpassed human capabilities in various tasks, yet the opacity of complex models limits their adoption in critical fields such as healthcare. Explainable AI (XAI) has emerged to address this by enhancing transparency and trust in AI decision-making. However, a persistent gap exists between interpretability and performance, as black-box models, such as deep neural networks, often outperform white-box models, such as regression-based approaches. To bridge this gap, the Explainable Boosting Machine (EBM), a class of generalized additive models has been introduced, combining the strengths of interpretable and high-performing models. EBM may be particularly well-suited for cognitive health research, where traditional models struggle to capture nonlinear effects in cognitive aging and account for inter- and intra-individual variability. Methods: This cross-sectional study applies EBM to investigate the relationship between demographic, environmental, and lifestyle factors, and cognitive performance in a sample of 3,482 healthy older adults. The EBM's performance is compared against Logistic Regression, Support Vector Machines, Random Forests, Multilayer Perceptron, and Extreme Gradient Boosting, evaluating predictive accuracy and interpretability. Results: The findings reveal that EBM provides valuable insights into cognitive aging, surpassing traditional models while maintaining competitive accuracy with more complex machine learning approaches. Notably, EBM highlights variations in how lifestyle activities impact cognitive performance, particularly differences between engaging in and refraining from specific activities, challenging regression-based assumptions. Moreover, our results show that the effects of lifestyle factors are heterogeneous across cognitive groups, with some individuals demonstrating significant cognitive changes while others remain resilient to these influences. Discussion: These findings highlight EBM's potential in cognitive aging research, offering both interpretability and accuracy to inform personalized strategies for mitigating cognitive decline. By bridging the gap between explainability and performance, this study advances the use of XAI in healthcare and cognitive aging research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.